Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (293)	5/18/1999 10:03:00 AM
From: scaram(o)uche	Read Replies (2) \| Respond to of 3559

biz.yahoo.com We need to find a new job for Dr. Schleifer......... one that's good for someone who moves at his speed.... tortoise farmer? Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of Regeneron, commented, ''NT-3 is known to have an important function in neural control of the gut. The larger clinical studies that we expect to start later this year will provide important information about the potential use of NT-3 as a drug for serious constipating conditions that currently have no effective treatment.''